New editions of "Music Score," Tic, Toc, Choc, and Sonata–Divine Comedy–Faust–Garden of Eden–Goethe–Gretchen–Mephistopheles–Paradise Lost–Allegro are published by Workroom Specter. earlier work …

Initially trained as a pianist, Min Oh explores how the body perceives, engages with, and generates time at the intersection of visual art, music, and dance, as well as where time-based installations and live performances converge.

Min Oh is a Senior Applied Scientist in AI Architecture and Strategy team at Microsoft Research. His research interests lie in machine intelligence to accelerate drug discovery and precision medicine. He received his PhD from Virginia Tech, focusing on deep learning for enhancing precision medicine. Opens in a new tab

Min Oh. Senior Applied Scientist at Microsoft Research. Verified email at microsoft.com. Deep Learning Drug Discovery Precision Medicine. Articles Cited by Public access Co-authors. Title. ... C Chen, CA Pankow, M Oh, LS Heath, L Zhang, P Du, K Xia, A Pruden. Environment international 128, 233-243, 2019. 139: 2019:

Min-hwan Oh is an Associate Professor in the Graduate School of Data Science at Seoul National University. His primary research interests are in sequential decision making, reinforcement learning, bandit algorithms, optimization, statistical machine learning, and …

2024年11月8日 · New editions of "Music Score," Tic, Toc, Choc, and Sonata–Divine Comedy–Faust–Garden of Eden–Goethe–Gretchen–Mephistopheles–Paradise Lost–Allegro are published by Workroom Specter. (Video Interview) 2021 Korea Artists Online Q&A with Artists | Oh Min (KR). Organized by MMCA, Seoul, KR. (Text Interview) Heterophony of Heterochrony …

‪University of Washington‬ - ‪‪Cited by 691‬‬

Min Oh was born in Seoul, Korea. From time that she was 6 years old she was a pianist, and received her BM (piano performance) at Seoul National University in Seoul,…

Transforming Clinical Research with AI and Machine Learning AI and ML are revolutionizing clinical research by enhancing data analysis and decision-making. From biomarker discovery to patient...